An ethics complaint leads to a resignation, and the agency shifts approval standards.

The government isn’t the only arbiter of product quality.

The U.S. Food and Drug Administration said on Thursday it has awarded six more companies, including Eli Lilly and Novo ...

The FDA approved lumateperone (Caplyta) as an adjunctive therapy with antidepressants for the treatment of major depressive ...

The head of the U.S. Food and Drug Administration’s drug division, Dr. George F. Tidmarsh, resigned on November 2, 2025, one ...

The FDA warning letters mostly went to cosmetic websites. In each case, the FDA said the companies were offering unofficial ...

The FDA has sent warning letters to 18 websites selling counterfeit or unapproved versions of Botox and similar injectable ...

Eli Lilly expects the U.S. Food and Drug Administration to approve its experimental oral obesity drug, orforglipron, by March ...

FDA issues Class II recall for ADHD drug after quality concerns, with millions of prescriptions potentially impacted.

Botulinum toxin, commonly called Botox, is used to temporarily reduce wrinkles by paralyzing facial muscles. While it is ...

The administration, as well as HHS, publicly praised Marty Makary’s leadership despite persistent upheaval at the agency.

The U.S. FDA approved a pricey rare disease drug in September despite findings by its data reviewers that the treatment, ...